{"corpus_id":6807054,"paper_sha":"b8494588f95ad0a13425ba87352fdbf1c7c9b52c","doi":"10.1136/bmj.326.7400.1167","arxiv_id":null,"pmid":12775614,"pmcid":"PMC156458","mag_id":2136284733,"dblp_id":null,"acl_id":null,"title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","year":2003,"publication_date":"2003-05-29","venue":"British medical journal","journal":{"name":"BMJ : British Medical Journal","pages":"1167 - 1170","volume":"326"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't","Systematic Review"],"s2_fields_of_study":["Medicine","Business"],"reference_count":77,"citation_count":2044,"influential_citation_count":23,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Clinical Trials as Topic","mj":false,"qs":[{"q":"standards","mj":false,"ui":"Q000592"}],"ui":"D002986"},{"d":"Drug Industry","mj":false,"qs":[{"q":"economics","mj":true,"ui":"Q000191"},{"q":"ethics","mj":false,"ui":"Q000941"},{"q":"standards","mj":false,"ui":"Q000592"}],"ui":"D004345"},{"d":"Financing, Organized","mj":false,"ui":"D005381"},{"d":"Publishing","mj":false,"qs":[{"q":"economics","mj":false,"ui":"Q000191"}],"ui":"D011643"},{"d":"Research","mj":false,"qs":[{"q":"standards","mj":true,"ui":"Q000592"}],"ui":"D012106"},{"d":"Research Support as Topic","mj":true,"ui":"D012109"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://www.bmj.com/content/bmj/326/7400/1167.full.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/b8494588f95ad0a13425ba87352fdbf1c7c9b52c","s2_open_access_license":null,"s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"OBJECTIVE: To investigate whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support. METHODS: Medline (January 1966 to December 2002) and Embase (January 1980 to December 2002) searches were supplemented with material identified in the references and in the authors' personal files. Data were independently abstracted by three of the authors and disagreements were resolved by consensus. RESULTS: 30 studies were included. Research funded by drug companies was less likely to be published than research funded by other sources. Studies sponsored by pharmaceutical companies were more likely to have outcomes favouring the sponsor than were studies with other sponsors (odds ratio 4.05; 95% confidence interval 2.98 to 5.51; 18 comparisons). None of the 13 studies that analysed methods reported that studies funded by industry was of poorer quality. CONCLUSION: Systematic bias favours products which are made by the company funding the research. Explanations include the selection of an inappropriate comparator to the product being investigated and publication bias.","claims":[{"public_id":"cl_24288eb9eb49a263a8c77705b3c30547","status":"active","text":"No analyzed methods study found poorer quality in industry-funded trials.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_24288eb9eb49a263a8c77705b3c30547"},{"public_id":"cl_f73267c7186246b687ecf84bfcbb9d0c","status":"active","text":"Research funded by drug companies was less likely to be published than research funded by other sources.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f73267c7186246b687ecf84bfcbb9d0c"},{"public_id":"cl_a040f5a6719969d436dc9318e11df8ad","status":"active","text":"Studies sponsored by pharmaceutical companies were more likely to report outcomes favoring the sponsor than studies with other sponsors.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_a040f5a6719969d436dc9318e11df8ad"},{"public_id":"cl_baebca130310afeb279fac370fa2c110","status":"active","text":"Systematic bias favors products made by the company funding the research.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_baebca130310afeb279fac370fa2c110"}],"concepts":[{"public_id":"co_22446f77a96f79b2bce4baf058c7bafa","status":"active","name":"studies sponsored by pharmaceutical companies","description":"Studies whose sponsor is a pharmaceutical company.","types":["study type"],"aliases":["pharmaceutical company-sponsored studies"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_22446f77a96f79b2bce4baf058c7bafa"},{"public_id":"co_2b27af0517304242ea238f2d7f947655","status":"active","name":"trial quality","description":"The methodological quality of a clinical trial, including aspects such as design and execution.","types":["quality measure"],"aliases":["methodological quality"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2b27af0517304242ea238f2d7f947655"},{"public_id":"co_3a83d2a7616a1b8ada5a2ec97ccfb5ad","status":"active","name":"outcomes favoring the sponsor","description":"Study outcomes that are more favorable to the sponsoring entity's product or interests.","types":["outcome"],"aliases":["favorable to the sponsor"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3a83d2a7616a1b8ada5a2ec97ccfb5ad"},{"public_id":"co_6b19d9fc94c36124c920d49cdf73b60a","status":"active","name":"product comparator selection","description":"The choice of a comparison treatment or control used in a study.","types":["methodological feature"],"aliases":["comparator selection"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6b19d9fc94c36124c920d49cdf73b60a"},{"public_id":"co_99e74e87e966c01ab5215437b535ed5b","status":"active","name":"publication bias","description":"Selective publication of studies depending on their results.","types":["bias"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_99e74e87e966c01ab5215437b535ed5b"},{"public_id":"co_bc739165176bed6aab73c0d75052bbab","status":"active","name":"systematic bias","description":"A consistent directional distortion in research findings or reporting.","types":["bias"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_bc739165176bed6aab73c0d75052bbab"},{"public_id":"co_bd625d5bd99afb2a53e48721e29231ed","status":"active","name":"industry-funded trials","description":"Clinical trials supported by industrial sponsors, here pharmaceutical companies.","types":["trial"],"aliases":["industry-funded studies"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_bd625d5bd99afb2a53e48721e29231ed"},{"public_id":"co_db9ed4a41ab4e8f82fd55013df9476f7","status":"active","name":"pharmaceutical industry sponsorship","description":"Funding or sponsorship of research by pharmaceutical companies.","types":["funding source"],"aliases":["industry sponsorship","pharmaceutical company funding"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_db9ed4a41ab4e8f82fd55013df9476f7"},{"public_id":"co_fce53dcd206b4ea9103d9c812d158706","status":"active","name":"research funded by drug companies","description":"Studies supported financially by drug manufacturers.","types":["funding source"],"aliases":["drug company-funded research"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fce53dcd206b4ea9103d9c812d158706"}],"external_ids":{"DOI":"10.1136/bmj.326.7400.1167","ArXiv":null,"PubMed":12775614,"PubMedCentral":"PMC156458","MAG":2136284733,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.bmj.com/content/bmj/326/7400/1167.full.pdf","landing_url":"https://www.semanticscholar.org/paper/b8494588f95ad0a13425ba87352fdbf1c7c9b52c","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":null,"status":"BRONZE","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631655,"paper_uid":"1d5147e0-bbd9-495c-ab52-fe0c52c9d22c","canonical_identity":{"paper_id":631655,"paper_uid":"1d5147e0-bbd9-495c-ab52-fe0c52c9d22c","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/6807054"}